Table 4 Mutation pattern noticed in SARS-CoV-2 Omicron BA.2.75.

From: Genomic characterization of Influenza A (H1N1)pdm09 and SARS-CoV-2 from Influenza Like Illness (ILI) and Severe Acute Respiratory Illness (SARI) cases reported between July–December, 2022

S. no.

SARS-CoV-2 proteins

Mutational sites

 

Spike protein

T19I, L24S, I210V, V213G, G257S, G339H, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, G446S, N460K, S477N, T478K, E484A, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K

 

ORF1a

S135R, T842I, S1221L, G1307S, P1640S, L3027F, T3090I, L3201F, T3255I, P3395H and N4060S

 

ORF1b

P314L, G662S, R1315C, I1566V and T2163I

 

ORF3a

T223I

 

E protein

T9I and T11A,

 

M protein

Q19E and A63T,

 

ORF6

D61L

 

ORF8

S84L

 

N protein

P13L, R203K, G204R and S413R

Back to article page